Literature DB >> 12423109

A novel stereocontrolled synthesis of cis-fused bicyclic lactams via [3 + 2]-cycloaddition of alkynyltungsten complexes with tethered aziridines.

Reniguntala J Madhushaw1, Chu-Chen Hu, Rai-Shung Liu.   

Abstract

Treatment of alkynyltungsten complexes with tethered aziridines in the presence of BF(3).Et(2)O led to [3 + 2]-cycloaddition reactions, affording bicyclic tungsten-enamine species stereoselectively. The stereochemistry of the resulting product reveals that ring opening of aziridine is initiated by S(N)2 attack of the tungsten fragment. Decomplexation of these organometallics with I(2) in CH(2)Cl(2), followed by hydrolysis, afforded only cis-fused bicyclic lactams efficiently. [reaction: see text]

Entities:  

Year:  2002        PMID: 12423109     DOI: 10.1021/ol0201862

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Tandem cyclization of alkynes via rhodium alkynyl and alkenylidene catalysis.

Authors:  Jung Min Joo; Yu Yuan; Chulbom Lee
Journal:  J Am Chem Soc       Date:  2006-11-22       Impact factor: 15.419

2.  The enantiomeric scaffold approach to highly functionalized 1-oxadecalines: enantio- and regiocontrolled [4 + 2] cycloadditions of 5-alkenyl-eta3-pyranylmolybdenum complexes.

Authors:  Ramón Gómez Arrayás; Jingjun Yin; Lanny S Liebeskind
Journal:  J Am Chem Soc       Date:  2007-02-14       Impact factor: 15.419

3.  Phosphine-Promoted [4 + 3] Annulation of Allenoate with Aziridines for Synthesis of Tetrahydroazepines: Phosphine-Dependent [3 + 3] and [4 + 3] Pathways.

Authors:  Honglei Liu; Yan Lin; Yan Zhao; Miaoren Xiao; Leijie Zhou; Qijun Wang; Cheng Zhang; Dongqi Wang; Ohyun Kwon; Hongchao Guo
Journal:  RSC Adv       Date:  2019-01-09       Impact factor: 4.036

4.  General Pyrrolidine Synthesis via Iridium-Catalyzed Reductive Azomethine Ylide Generation from Tertiary Amides and Lactams.

Authors:  Ken Yamazaki; Pablo Gabriel; Graziano Di Carmine; Julia Pedroni; Mirxan Farizyan; Trevor A Hamlin; Darren J Dixon
Journal:  ACS Catal       Date:  2021-06-09       Impact factor: 13.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.